Tham khảo Mirogabalin

  1. ↑ Vinik, A; Rosenstock, J; Sharma, U; Feins, K; Hsu, C; Merante, D (tháng 12 năm 2014). “Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study”. Diabetes Care. 37 (12): 3253–61. doi:10.2337/dc14-1044. PMID 25231896. Đã bỏ qua tham số không rõ |displayauthors= (gợi ý |display-authors=) (trợ giúp)
  2. ↑ Vinik, A; Sharma, U; Feins, K; Hsu, C; Merante, D (2014). “DS-5565 for the Treatment Of Diabetic Peripheral Neuropathic Pain: Randomized, Double-Blind, Placebo- And Active Comparator-Controlled Phase II Study (S20.004)”. Neurology. 82 (10): S20.004.
  3. ↑ “Daiichi Sankyo Announces Top-line Results from Phase 3 Global Clinical Development Program Evaluating Mirogabalin in Pain Syndromes”. Daiichi Sankyo. ngày 30 tháng 6 năm 2017.
  4. ↑ “Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain”. Daiichi Sankyo. ngày 31 tháng 8 năm 2017.
  5. ↑ “Daiichi Sankyo Submits Marketing Application for Mirogabalin in Japan”. Daiichi Sankyo. ngày 15 tháng 2 năm 2018.
  6. ↑ https://adisinsight.springer.com/drugs/800033181

Tài liệu tham khảo

WikiPedia: Mirogabalin http://www.chemspider.com/Chemical-Structure.32701... //pubmed.ncbi.nlm.nih.gov/25231896 http://www.kegg.jp/entry/D11203 http://www.commonchemistry.org/ChemicalDetail.aspx... //doi.org/10.2337%2Fdc14-1044 http://www.neurology.org/content/82/10_Supplement/... https://www.daiichisankyo.com/media_investors/medi... https://www.daiichisankyo.com/media_investors/medi... https://www.daiichisankyo.com/media_investors/medi... https://adisinsight.springer.com/drugs/800033181